Minimal specimen requirements make it suitable for a wide range of tumor types and practice settings. The assay builds on the company’s tissue-based CGP platform, previously known as NeoComprehensive ...

Imagine that you want to know the plot of a movie, but you only have access to either the visuals or the sound. With visuals ...

Dax Kurbegov, MD, discusses findings from the CORE-HH study that build on growing evidence to support the clinical ...

GENCURIX partnership marks launch of new QIAcuityDx Partnering Program for third-party in vitro diagnostic (IVD) assay development GENCURIX signs as inaugural partner to develop multiplex oncology ...

Advanced imaging technologies are uncovering surprising roles for CD8+ T cells—not just in immune defense, but also in supporting tissue repair and regeneration.

Shares in radiology imaging giant Promedicus today soared almost 10% on two client wins worth $190 million in revenue.

Durham-based GeneCentric Therapeutics, a cancer diagnostics company, has closed on an $8 million round of venture capital to launch and commercialize a novel liquid biopsy platform for guiding ...

ANGLE presents new data at EACR 2025 Highlighting Innovation in Androgen Receptor EXPRESSION profilingPoster presentation highlights development of a novel CTC-based assay GUILDFORD, SURREY / ACCESS N ...

Whether antiretroviral therapy (ART) is always completely suppressive, or HIV might continue to replicate at low levels despite ART in some people with HIV (PWH), is still debated. Here, we ...

Interaction-based biomarker assays Individual proteins have long been used as diagnostic markers in cancer tissue samples, such as Her-2 detection for trastuzumab (Herceptin) treatment guidance.

1 Genoptix Medical Laboratory, Carlsbad, CA, USA. 2 Yale University School of Medicine, New Haven, CT, USA 3 Clinical Development Laboratory, Merck & Company, Office: RY50-1E-144, Maildrop RY 50 ...

Source Reference: Bryan ME, et al "Direct comparison of alternative blood-based approaches for early detection and diagnosis of HPV-associated head and neck cancers" Clin Cancer Res 2025; DOI: 10. ...